[47] Pinkerton J. V., Sánchez Aguirre F., Blake J., Cosman F., Hodis H. N., Hofstetter S., Kaunitz A. M., Kingsberg S. A., Maki P. M., Manson J. E., Marchbanks P., McClung M. R., Nachtigall L. E., Nelson L. M., Pace D. T., Reid R. L., Sarrel P. M., Shifren J. L., Stuenkel C. A., Utian W. H. The 2017 hormone therapy position statement of The North American Menopause Society. The NAMS 2017 Hormone Therapy Position Statement Advisory Panel. Menopause. 2017 Jul; 24 (7): 728–753.
[48] Stuenkel C. A., Davis S. R., Gompel A., Lumsden M. A., Murad M. H., Pinkerton J. V., Santen R. J. Treatment of Symptoms of the Menopause: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2015 Nov; 100 (11): 3975–4011.
[49] Santen R. J., Stuenkel C. A., Burger H. G., Manson J. E. Competency in menopause management: whither goest the internist? J Womens Health (Larchmt). 2014 Apr; 23 (4): 281–285.
[50] Gass M., Larson J., Cochrane B., Manson J. E., Lane D., Barnabei V., Ockene J., Stefanick M. L., Mouton C. Sexual activity and vaginal symptoms in the postintervention phase of the Women's Health Initiative Hormone Therapy Trials. Menopause. 2018 Mar; 25 (3): 252–264.
[51] Bühling K. J., von Studnitz F. S., Jantke A., Eulenburg C., Mueck A. O. Use of hormone therapy by female gynecologists and female partners of male gynecologists in Germany 8 years after the Women's Health Initiative study: results of a survey. Menopause. 2012 Oct; 19 (10): 1088–1091.
[52] Biglia N., Cozzarella M., Ponzone R., Marenco D., Maggiorotto F., Fuso L., Sismondi P. Personal use of HRT by postmenopausal women doctors and doctors’ wives in the north of Italy. Gynecol Endocrinol. 2004 Mar; 18 (3): 165–174.
[53] Lindau S. T., Gavrilova N. Sex, health, and years of sexually active life gained due to good health: evidence from two US population based cross sectional surveys of ageing. BMJ. 2010 Mar 9; 340: c810.
[54] Goldin, Claudia and Lawrence F. Katz. 2002. The power of the pill: Oral contraceptives and women's career and marriage decisions. Journal of Political Economy 110 (4): 730–770.
[55] Institute for Quality and Efficiency in Health Care 2006 Informed Health Online Contraception: Do hormonal contraceptives cause weight gain?
[56] Gallo M. F., Lopez L. M., Grimes D. A., Carayon F., Schulz K. F., Helmerhorst FM. Combination contraceptives: effects on weight. Cochrane Database Syst Rev. 2014 Jan 29; (1).
[57] Øjvind Lidegaard, professor of obstetrics and gynaecology, Lars Hougaard Nielsen, statistician, Charlotte Wessel Skovlund, data manager and scientific assistant, Finn Egil Skjeldestad, professor of clinical medicine, and Ellen L kkegaard, senior registrar in obstetrics and gynaecology. Risk of venous thromboembolism from use of oral contraceptives containing diferent progestogens and oestrogen doses: Danish cohort study, 2001–9 BMJ. 2011; 343: d6423.
[58] Lidegaard Ø., Løkkegaard E., Jensen A., Skovlund C.W., Keiding N. Thrombotic stroke and myocardial infarction with hormonal contraception. N Engl J Med. 2012 Jun 14; 366 (24): 2257–2266.
[59] Blanco-Molina A., Monreal M. Venous thromboembolism in women taking hormonal contraceptives Expert Rev Cardiovasc Ther. 2010 Feb; 8 (2): 211–215.
[60] Urban M., Banks E., Egger S., Canfell K., O'Connell D., Beral V., Sitas F. Injectable and oral contraceptive use and cancers of the breast, cervix, ovary, and endometrium in black South African women: case-control study. PLoS Med. 2012; 9 (3): e1 001182.
[61] Gierisch J. M., Coeytaux R. R., Urrutia R. P., Havrilesky L. J., Moorman P. G., Lowery W. J., Dinan M., McBroom A. J., Hasselblad V., Sanders G. D., Myers E. R. Oral contraceptive use and risk of breast, cervical, colorectal, and endometrial cancers: a systematic review. Cancer Epidemiol Biomarkers Prev. 2013 Nov; 22 (11): 1931–1943.
[62] Archer J. S., Archer D. F. Oral contraceptive efficacy and antibiotic interaction: a myth debunked. J Am Acad Dermatol. 2002 Jun; 46 (6): 917–923.
[63] Dickinson B. D., Altman R. D., Nielsen N. H., Sterling M. L.; Council on Scientific Afairs, American Medical Association. Drug interactions between oral contraceptives and antibiotics. Obstet Gynecol. 2001 Nov; 98 (5 Pt 1): 853–860.
[64] Dal’Ava N., Bahamondes L., Bahamondes M. V., Bottura B. F., Monteiro I. Body weight and body composition of depot medroxyprogesterone acetate users. Contraception. 2014 Aug; 90 (2): 182–187.
[65] Dirk Wildemeersch, Norman Goldstuck, Thomas Hasskamp, Sohela Jandi, and Ansgar Pett. Intrauterine device quo vadis? Why intrauterine device use should be revisited particularly in nulliparous women? J Contracept. 2015; 6: 1–12.
[66] Hartmann L. C., Sellers T. A., Frost M. H., Lingle W. L., Degnim A. C., Ghosh K., Vierkant R. A., Maloney S. D., Pankratz V. S., Hillman D. W., Suman V. J., Johnson J., Blake C., Tlsty T., Vachon C. M., Melton L. J. 3rd, Visscher D. W. Benign breast disease and the risk of breast cancer. N Engl J Med. 2005 Jul 21; 353 (3): 229–237.
[67] Anthony Howell, Annie S. Anderson, Robert B. Clarke, Stephen W. Duffy, D. Gareth Evans, Montserat Garcia-Closas, Andy J. Gescher, Timothy J. Key, John M. Saxton, and Michelle N. Harvie. Risk determination and prevention of breast cancer. Breast Cancer Res. 2014; 16: 446.
[68] Hardefeldt P. J., Edirimanne S., Eslick G. D. Deodorant use and breast cancer risk. Epidemiology. 2013 Jan; 24 (1): 172.
[69] Obwohl es Hinweise einer holl ndischen Forschungsgruppe gibt, dass Implantate extrem selten einen anaplastischen großzelligen Lymphom auslösen können. Mintsje de Boer; Flora E. van Leeuwen; Michael Hauptmann; Lucy I. H. Overbeek; Jan Paul de Boer; Nathalie J. Hijmering; Arthur Sernee; Caroline A. H. Klazen; Marc B. I. Lobbes; René R.W. J. van der Hulst; Hinne A. Rakhorst; Daphne de Jong. Breast Implants and the Risk of Anaplastic Large-Cell Lymphoma in the Breast. JAMA Oncol. 2018; 4 (3): 335–341.
[70] Kamal Kataria, Anita Dhar, Anurag Srivastava, Sandeep Kumar, and Amit Goyal. A Systematic Review of Current Understanding and Management of Mastalgia. Indian J Surg. 2014 Jun; 76 (3): 217–222.
[71] Christina Stenhammar, Ylva Tiblom Ehrsson, Helena Akerud, Margareta Larsson, and Tanja Tydén Sexual and contraceptive behavior among female university students in Sweden – repeated surveys over a 25-year period. Acta Obstet Gynecol Scand. 2015 Mar; 94 (3): 253–259.
